OBJECTIVE: The aim of this study was to determine the smallest worthwhile effects of two treatments for nonspecific low back pain (LBP). STUDY DESIGN AND SETTING: The benefit-harm trade-off method was used to estimate the smallest worthwhile effect of nonsteroidal anti-inflammatory drugs (NSAIDs) and physiotherapy for LBP. Patients seeking care for chronic LBP were interviewed by telephone before treatment commenced and 4 weeks later. RESULTS: Patients need to see a median of 30% (interquartile range [IQR]: 10-40) more improvement in pain and 20% (IQR: 10-40) more improvement in disability than would occur without intervention to perceive the effect of NSAIDs are worthwhile. They would need to see 20% (IQR: 0-30) more improvement on pain and disability over natural recovery to perceive that the effect of physiotherapy was worthwhile. There was no difference in estimates of the smallest worthwhile effect elicited at baseline and 4 weeks later. CONCLUSIONS: People with chronic back pain need to see larger effects on pain of NSAIDS than physiotherapy to consider the effects of these interventions worthwhile. These estimates of the smallest worthwhile effect can be used to interpret the findings of clinical trials and to design adequately powered clinical trials.
OBJECTIVE: The aim of this study was to determine the smallest worthwhile effects of two treatments for nonspecific low back pain (LBP). STUDY DESIGN AND SETTING: The benefit-harm trade-off method was used to estimate the smallest worthwhile effect of nonsteroidal anti-inflammatory drugs (NSAIDs) and physiotherapy for LBP. Patients seeking care for chronic LBP were interviewed by telephone before treatment commenced and 4 weeks later. RESULTS:Patients need to see a median of 30% (interquartile range [IQR]: 10-40) more improvement in pain and 20% (IQR: 10-40) more improvement in disability than would occur without intervention to perceive the effect of NSAIDs are worthwhile. They would need to see 20% (IQR: 0-30) more improvement on pain and disability over natural recovery to perceive that the effect of physiotherapy was worthwhile. There was no difference in estimates of the smallest worthwhile effect elicited at baseline and 4 weeks later. CONCLUSIONS:People with chronic back pain need to see larger effects on pain of NSAIDS than physiotherapy to consider the effects of these interventions worthwhile. These estimates of the smallest worthwhile effect can be used to interpret the findings of clinical trials and to design adequately powered clinical trials.
Authors: Oliver Enke; Heather A New; Charles H New; Stephanie Mathieson; Andrew J McLachlan; Jane Latimer; Christopher G Maher; C-W Christine Lin Journal: CMAJ Date: 2018-07-03 Impact factor: 8.262
Authors: Matthew Fernandez; Manuela L Ferreira; Kathryn M Refshauge; Jan Hartvigsen; Isabela R C Silva; Chris G Maher; Bart W Koes; Paulo H Ferreira Journal: Eur Spine J Date: 2015-07-26 Impact factor: 3.134
Authors: Barbara C Sorkin; Adam J Kuszak; Gregory Bloss; Naomi K Fukagawa; Freddie Ann Hoffman; Mahtab Jafari; Bruce Barrett; Paula N Brown; Frederic D Bushman; Steven J Casper; Floyd H Chilton; Christopher S Coffey; Mario G Ferruzzi; D Craig Hopp; Mairead Kiely; Daniel Lakens; John B MacMillan; David O Meltzer; Marco Pahor; Jeffrey Paul; Kathleen Pritchett-Corning; Sara K Quinney; Barbara Rehermann; Kenneth D R Setchell; Nisha S Sipes; Jacqueline M Stephens; D Lansing Taylor; Hervé Tiriac; Michael A Walters; Dan Xi; Giovanna Zappalá; Guido F Pauli Journal: FASEB J Date: 2019-12-10 Impact factor: 5.834
Authors: Emma K Ho; Manuela L Ferreira; Adrian Bauman; Paul W Hodges; Christopher G Maher; Milena Simic; Rachael L Morton; Chris Lonsdale; Qiang Li; Melissa T Baysari; Anita B Amorim; Dragana Ceprnja; Ornella Clavisi; Mark Halliday; Matthew Jennings; Alice Kongsted; Katherine Maka; Kate Reid; Tahlia Reynolds; Paulo H Ferreira Journal: BMC Musculoskelet Disord Date: 2021-07-09 Impact factor: 2.362
Authors: Aidan G Cashin; Thiago Folly; Matthew K Bagg; Michael A Wewege; Matthew D Jones; Michael C Ferraro; Hayley B Leake; Rodrigo R N Rizzo; Siobhan M Schabrun; Sylvia M Gustin; Richard Day; Christopher M Williams; James H McAuley Journal: BMJ Date: 2021-07-07